Discovery of Novel Biomarkers for Alzheimer's Disease from Blood
- Submitting institution
-
University of Plymouth
- Unit of assessment
- 12 - Engineering
- Output identifier
- 106
- Type
- D - Journal article
- DOI
-
10.1155/2016/4250480
- Title of journal
- Disease Markers
- Article number
- 4250480
- First page
- -
- Volume
- 2016
- Issue
- -
- ISSN
- 0278-0240
- Open access status
- Compliant
- Month of publication
- -
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
4
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- Blood-based biomarkers have the potential to provide a cost and time efficient way to detect the early stages of Alzheimer's disease (AD) and complement techniques such as neuroimaging, which is used to confirm diagnosis. This paper is significant as it identifies a small panel of biomarkers that can be used to diagnose AD accurately in clinical practice. Further research is in progress funded by EPSRC (project EP/M006301/1) and EU (H2020 MSCA Project 721281) to develop novel biosensors underpinned by intelligent models to embed this technology in a diagnostic point-of-care device.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -